等待開盤 02-07 09:30:00 美东时间
+0.450
+1.94%
今日重点评级关注:Ascendiant Capital:维持SurgePays Inc"买入"评级,目标价从9.5美元升至9.75美元;Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从8美元升至10美元
2025-12-23 12:32
Deutsche Bank analyst Cave Montazeri maintains Neptune Insurance Hldgs (NYSE:NP) with a Buy and raises the price target from $29 to $31.
2025-12-23 02:37
Financial stocks (XLF) largely drifted higher, while the broader S&P 500 slipped in the past week, which was marked by the Federal Reserve's third consecutive interest-rate cut. Enova International (E...
2025-12-13 23:10
Cramer chose not to recommend Marvell Technology, Inc. but advised holding on to Howmet Aerospace Inc. and Chubb.
2025-11-25 20:51
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
B of A Securities analyst Joshua Shanker maintains Neptune Insurance Hldgs (NYSE:NP) with a Underperform and raises the price target from $21 to $22.5.
2025-11-13 20:52
Neptune Insurance Hldgs (NYSE:NP) sees FY2026 sales of $186.000 million-$189.000 million vs $187.372 million analyst estimate.
2025-11-13 05:20
Neptune Insurance Hldgs (NYSE:NP) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 15.38 percent. This is a 33.33 percent increase over earnings of $0.09 per share from
2025-11-13 05:17
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
2025-10-29 09:25